Article Correctness Is Author's Responsibility: UTHealth joins trial to test antibodies and other experimental outpatient COVID treatments

(University of Texas Health Science Center at Houston) A study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth).